Form 8-K - Current report:
SEC Accession No. 0001140361-25-017704
Filing Date
2025-05-07
Accepted
2025-05-07 16:12:24
Documents
16
Period of Report
2025-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20048524_8k.htm   iXBRL 8-K 32020
2 EXHIBIT 99.1 ef20048524_ex99-1.htm EX-99.1 253580
6 GRAPHIC image00001.jpg GRAPHIC 4891
7 GRAPHIC image00002.jpg GRAPHIC 4876
  Complete submission text file 0001140361-25-017704.txt   457181

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA adma-20250505.xsd EX-101.SCH 3997
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20250505_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20250505_pre.xml EX-101.PRE 16054
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20048524_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 25921490
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)